PAREXEL Biopharmaceutical Parexel Biopharmaceutical Statistical Sourcebook 2005-2006 (Hardcopy) - $295.00
With 33% more new analyses and presentations this year!
Now industry's most widely read reference on emerging pharma/biotech R&D trends, PAREXEL's Pharmaceutical R&D Statistical Sourcebook 2005/2006 features hundreds of pages of all-new, real-world studies, analyses, articles, and data sets providing fresh insights into the developments reshaping pharma R&D and the industry itself.
Supported by thousands of graphs, illustrations, and analyses, PAREXEL's Pharmaceutical R&D Statistical Sourcebook provides the latest intelligence on every aspect of pharmaceutical development--from product discovery to R&D performance and productivity to time-to-market trends.
An invaluable resource for executives and managers working within or with the pharma and biotech industries, this 2005/2006 compendium puts real-world data sets at your fingertips for presentations, reports, business development efforts, meetings, and critical decision-making analyses:
- New R&D Spending Trends (U.S. and Global)
- Emerging Data on the Worldwide and Company-specific R&D Pipelines and Product Launch Trends
- New Analyses on Drug Development Costs/Development Cycle Times/Attrition Rates
- Drug Approval Statistics Compiled from FDA, EMEA and other Key Regulatory Agencies
- International R&D Data from Key Global Markets
From advances in clinical trial simulation and genomics to emerging trends in industry's product pipeline and product success rates to the new demographics of US clinical investigators and clinical trial populations, make sure that your meetings, reports, presentations, and decision-making are based on the very best and latest data available today!
"PAREXEL's Pharmaceutical R&D Statistical Sourcebook is one of the most important sources for accurate industry and regulatory data, and for some tables it is the only source."
Bert Spilker, President, Bert Spilker & Associates, LLC
"This is an incredibly useful and reliable resource for anyone connected to the pharmaceutical and biotech industries: marketers, financial planners, investors, or researchers. I highly recommend it."
Judy Blaine, Librarian, ArQule, Inc. as printed in Business Information Alert
Get your copy of the leading compendium of pharma/biotech R&D trend data and market intelligence!
Approx. 400 pp., Hardcover